Onconova Therapeutics, Inc. Profile Avatar - Palmy Investing

Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that …

Biotechnology
US, Newtown [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ONTX's Analysis
CIK: 1130598 CUSIP: 68232V801 ISIN: US68232V8019 LEI: - UEI: -
Secondary Listings
ONTX has no secondary listings inside our databases.